Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D013311:Streptozocin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
C007028:chlorozotocin; D013311:Streptozocin